Literature DB >> 34373485

Repeatability and comparability of the Galilei-G4 and Cassini in measuring corneal power and astigmatism in normal and post-refractive surgery eyes.

Mohamed Mohamed1, Mahmood Khan2, Amritha Kanakamedala1, Isha Gupta1, Li Wang1, Douglas Koch1, Zaina Al-Mohtaseb3.   

Abstract

To assess the repeatability and comparability of the Galilei G4 versus the Cassini topographer in post-refractive eyes and in normal eyes, including older patients representative of an initial cataract evaluation. Simulated keratometric (simK), total corneal and posterior corneal power and astigmatism were evaluated in both post-refractive and normal eyes. Repeatability was measured by calculating within-subject standard deviation (Sw), coefficient of variation (CoV), and intraclass correlation coefficient (ICC). Vector analyses and Bland-Altman plots were employed to assess agreement between devices. We studied 32 subjects with a history of refractive surgery and 32 subjects without a history of refractive surgery undergoing cataract surgery. The mean age was 55 ± 18.5 years and the age range was 21.5-91.5 years. In non-refractive and post-refractive eyes, the ICC was > 0.9 (P < 0.001) for all corneal powers and for simK and total corneal astigmatism for both analyzers. The ICC for posterior corneal astigmatism magnitude using the Galilei was 0.62 and 0.67 and for the Cassini 0.55 and 0.38 in normal and post-refractive eyes, respectively. In both post-refractive and normal eyes, the Galilei G4 and Cassini analyzers have high repeatability in simK, total, and posterior corneal power and low repeatability for posterior corneal astigmatism.
© 2021. The Author(s).

Entities:  

Year:  2021        PMID: 34373485     DOI: 10.1038/s41598-021-94319-w

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  1 in total

1.  Comparison of Color Light-Emitting Diode Corneal Topographer and Dual Rotating Scheimpflug-Placido Topographer.

Authors:  Jae Hyuck Lee; Yong Woo Lee; Jong Soo Lee; Michael C Knorz; Gerd U Auffarth; Chul Young Choi
Journal:  J Ophthalmol       Date:  2018-12-27       Impact factor: 1.909

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.